PRC partners analysis"Since the AbbVie deal was announced, Sirona Biochem has been approached by several major institutions, funds and investment banking firms. Initial meetings have already taken place and will be followed up by high-profile meetings all over the world in the coming weeks. As far as we know, additional meetings will take place in Germany, France, the U.S and Canada."
"In a recent conversation with the current CEO, Dr. Howard Verrico, we were made aware that the company has already begun the process of looking for a suitable CEO, either one from Europe or a multi-lingual candidate, to take the company to the next level. Dr. Verrico would remain with the company as president and chairman of the board. "
"The animal health market may not be as large as the anti-aging market, but a deal with a top animal pharmaceutical company could still translate to tens of millions of dollars in royalty payments."
57ea05_4dfabf8ca3aa4f9e929d16bcfcc954dd.pdf (usrfiles.com)